The_DT
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
ORI1yt_NN
enhancer_NN
is_VBZ
not_RB
B-cell_NN
specific_JJ
and_CC
does_VBZ
not_RB
respond_VB
synergistically_RB
to_TO
the_DT
EBV_NN
transcription_NN
factors_NNS
R_NN
and_CC
Z_NN
._.

The_DT
Epstein-Barr_JJ
virus_NN
DR_NN
promoter_NN
is_VBZ
located_JJ
upstream_JJ
of_IN
the_DT
PstI_NN
repeats_NNS
,_,
and_CC
in_IN
addition_NN
to_TO
the_DT
TATA_NN
box_NN
,_,
it_PRP
contains_VBZ
an_DT
upstream_JJ
region_NN
-LRB-_-LRB-
positions_NNS
-69_CD
to_TO
-220_CD
-RRB-_-RRB-
responsive_JJ
to_TO
EB1_NN
-LRB-_-LRB-
Z_NN
-RRB-_-RRB-
-LRB-_-LRB-
the_DT
BZLF1-encoded_JJ
transcription_NN
factor_NN
-RRB-_-RRB-
and_CC
an_DT
enhancer_NN
with_IN
two_CD
functionally_RB
distinct_JJ
domains_NNS
,_,
A_NN
and_CC
B_NN
._.

Domain_NN
B_NN
has_VBZ
been_VBN
described_VBN
as_IN
a_DT
B-cell-specific_JJ
EB1-responsive_JJ
element_NN
-LRB-_-LRB-
P.M._NNP
Lieberman_NNP
,_,
J.M._NNP
Hardwick_NNP
,_,
and_CC
S.D._NN
Hayward_NN
,_,
J._NNP
Virol_NNP
.63_CD
:_:
3040-3050_CD
,_,
1989_CD
-RRB-_-RRB-
activated_VBN
synergistically_RB
by_IN
EB1_NN
and_CC
R_NN
,_,
an_DT
EBV_NN
early_JJ
product_NN
encoded_VBN
by_IN
the_DT
open_JJ
reading_NN
frame_NN
BRLF1_NN
-LRB-_-LRB-
M.A._NNP
Cox_NNP
,_,
J._NNP
Leahy_NNP
,_,
and_CC
J.M._NNP
Hardwick_NNP
,_,
J._NNP
Virol_NNP
.64_CD
:_:
313-321_CD
,_,
1990_CD
-RRB-_-RRB-
._.

We_PRP
show_VBP
here_RB
that_IN
domain_NN
B_NN
is_VBZ
an_DT
R-responsive_JJ
element_NN
in_IN
HeLa_NN
cells_NNS
and_CC
is_VBZ
therefore_RB
not_RB
an_DT
EB1-responsive_JJ
B-cell-specific_JJ
element_NN
._.

However_RB
,_,
there_EX
is_VBZ
an_DT
EB1-binding_JJ
site_NN
-LRB-_-LRB-
ZRE-B_NN
-RRB-_-RRB-
located_JJ
within_IN
the_DT
R-responsive_JJ
enhancer_NN
region_NN
._.

ZRE-B_NN
can_MD
be_VB
deleted_VBN
without_IN
affecting_VBG
the_DT
R-dependent_JJ
enhancer_NN
activity_NN
._.

Moreover_RB
,_,
there_EX
is_VBZ
no_DT
cooperation_NN
or_CC
synergy_NN
between_IN
R_NN
and_CC
EB1_NN
when_WRB
activating_VBG
the_DT
B_NN
domain_NN
-LRB-_-LRB-
ZRE-B_NN
plus_CC
the_DT
R-responsive_JJ
element_NN
-RRB-_-RRB-
positioned_JJ
as_IN
an_DT
enhancer_NN
._.

ZRE-B_NN
is_VBZ
therefore_RB
not_RB
part_NN
of_IN
the_DT
R-inducible_JJ
enhancer_NN
._.

We_PRP
have_VBP
tested_VBN
several_JJ
subregions_NNS
of_IN
the_DT
DR_NN
enhancer_NN
B_NN
domain_NN
,_,
either_CC
alone_RB
or_CC
in_IN
combination_NN
,_,
for_IN
their_PRP$
capacity_NN
to_TO
transmit_VB
the_DT
R-activating_JJ
signal_NN
to_TO
the_DT
rabbit_NN
beta-globin_NN
promoter_NN
._.

We_PRP
found_VBD
that_IN
the_DT
R-responsive_JJ
element_NN
is_VBZ
composed_VBN
of_IN
four_CD
protoenhancers_NNS
that_WDT
span_VBP
the_DT
whole_JJ
B_NN
domain_NN
._.

These_DT
protoenhancers_NNS
alone_RB
are_VBP
weakly_RB
or_CC
not_RB
responsive_JJ
to_TO
R_NN
._.

One_CD
of_IN
the_DT
protoenhancers_NNS
contains_VBZ
the_DT
overlapping_VBG
palindromes_NNS
5_CD
'_``
-_NN
TTGTCCcgtGGACAAaTGTCC-3_JJ
'_''
._.

However_RB
,_,
one_CD
palindrome_NN
,_,
either_CC
alone_RB
or_CC
duplicated_JJ
,_,
or_CC
the_DT
overlapping_VBG
palindromes_NNS
did_VBD
not_RB
respond_VB
to_TO
R_NN
._.

